ProfileGDS4459 / ENSG00000004534
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 88% 87% 90% 90% 90% 88% 88% 92% 91% 90% 89% 89% 94% 85% 91% 87% 87% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.8388
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.7187
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 37.3490
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 47.0190
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 57.3690
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.9688
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.9888
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 87.6692
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 97.5191
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 107.2590
GSM623474group B, liver allograft wedge biopsie placebo treatment 17.2989
GSM623475group B, liver allograft wedge biopsie placebo treatment 27.289
GSM623476group B, liver allograft wedge biopsie placebo treatment 37.9194
GSM623477group B, liver allograft wedge biopsie placebo treatment 46.3785
GSM623478group B, liver allograft wedge biopsie placebo treatment 57.5691
GSM623479group B, liver allograft wedge biopsie placebo treatment 66.6887
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.8287